E213 - Metabolic dysfunction–associated fatty liver disease an update
from Australian Prescriber Podcast
Laura Beaton talks to hepatology research fellow Richard O'Halloran about his paper on metabolic dysfunction–associated fatty liver disease (MAFLD). Richard outlines risk factors and comorbidities to consider, and diagnostic tests for MAFLD. The conversation also covers management of MAFLD through risk stratification, addressing health risk behaviours, and surveillance. Read the full article in Australian Prescriber.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Australian Prescriber Podcast?
This episode is 15 minutes long.
When was this Australian Prescriber Podcast episode published?
This episode was published on April 27, 2026.
Can I download this Australian Prescriber Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.